Finding 1147663 (2023-104)

Significant Deficiency
Requirement
L
Questioned Costs
-
Year
2023
Accepted
2025-07-14
Audit: 362092
Organization: Pancare of Florida, INC (FL)

AI Summary

  • Core Issue: The Organization lacks proper documentation and controls for reviewing reports before submission, risking incorrect information being sent to the grantor.
  • Impacted Requirements: This finding violates 2 CFR section 200.303, which mandates that entities maintain internal controls for managing federal awards.
  • Recommended Follow-Up: Implement a clear documentation process that tracks who prepared and reviewed the information, ensuring completeness and accuracy before submission.

Finding Text

2023-104 Lack of Controls Related to Filing Reports (initially reported 2023) Assistance Listing Number: 93.224 and 93.527 Name of Federal Agency: Department of Health and Human Services, HRSA Program Title: Health Center Program (Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) and Grants for New and Expanded Services Under the Health Center Program Compliance Requirement: Reporting Pass-through Entity: N/A Federal Grant/Contract Number and Grant Year: H8006452 (2022 and 2023), H2E45500 (2022), COVID-19 ARP H8F40324 (2021), H8K49674 (2023), C1439909 (2020), H2E50094 (2023), COVID-19 H8L50549 (2023) and COVID-19 H8G48569 (2022) Finding Type: Significant Deficiency in Internal Control Questioned Costs: $0 Condition: The Organization did not maintain proper documentation to support the review of the report prior to submission to the grantor, other than the review done by the preparer. Criteria: 2 CFR section 200.303 requires that nonfederal entities receiving federal awards establish and maintain internal control over the federal awards that provides reasonable assurance that the nonfederal entity is managing the federal awards in compliance with federal statutes, regulations, and the terms and conditions of the federal awards. Cause: The Organization did not have a process in place for review of the data being reported on the HRSA website for the funds being expensed under the federal award programs. Effect: The Organization could submit incorrect information. Recommendation: The documentation should be kept that clearly documents who prepared the information, who reviewed the information, and that the reviewer considered whether the information was complete and accurate. Views of Responsible Officials and Planned Corrective Actions: The Organization has hired a new Chief Financial Officer as well as additional supporting staff within the finance department. The accounting staff was restructured in November 2024 with the addition of a Finance Manager and Senior Accountant to strengthen internal controls and facilitate segregation of duties best practices for day-to-day activities. In addition to review of month-end journal entries, reporting requirements with additional review was also implemented in 2025.

Categories

Internal Control / Segregation of Duties Subrecipient Monitoring HUD Housing Programs Reporting Significant Deficiency Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 571191 2023-101
    Material Weakness Repeat
  • 571192 2023-102
    Significant Deficiency Repeat
  • 571193 2023-104
    Significant Deficiency
  • 571194 2023-105
    Material Weakness
  • 571195 2023-106
    Significant Deficiency
  • 571196 2023-102
    Significant Deficiency Repeat
  • 571197 2023-104
    Significant Deficiency
  • 571198 2023-105
    Material Weakness
  • 571199 2023-106
    Significant Deficiency
  • 571200 2023-101
    Material Weakness Repeat
  • 571201 2023-102
    Significant Deficiency Repeat
  • 571202 2023-104
    Significant Deficiency
  • 571203 2023-105
    Material Weakness
  • 571204 2023-106
    Significant Deficiency
  • 571205 2023-102
    Significant Deficiency Repeat
  • 571206 2023-104
    Significant Deficiency
  • 571207 2023-102
    Significant Deficiency Repeat
  • 571208 2023-104
    Significant Deficiency
  • 571209 2023-102
    Significant Deficiency Repeat
  • 571210 2023-104
    Significant Deficiency
  • 571211 2023-105
    Material Weakness
  • 571212 2023-106
    Significant Deficiency
  • 571213 2023-101
    Material Weakness Repeat
  • 571214 2023-102
    Significant Deficiency Repeat
  • 571215 2023-104
    Significant Deficiency
  • 571216 2023-105
    Material Weakness
  • 571217 2023-106
    Significant Deficiency
  • 571218 2023-102
    Significant Deficiency Repeat
  • 571219 2023-104
    Significant Deficiency
  • 571220 2023-102
    Significant Deficiency Repeat
  • 571221 2023-104
    Significant Deficiency
  • 571222 2023-105
    Material Weakness
  • 571223 2023-106
    Significant Deficiency
  • 571224 2023-101
    Material Weakness Repeat
  • 1147633 2023-101
    Material Weakness Repeat
  • 1147634 2023-102
    Significant Deficiency Repeat
  • 1147635 2023-104
    Significant Deficiency
  • 1147636 2023-105
    Material Weakness
  • 1147637 2023-106
    Significant Deficiency
  • 1147638 2023-102
    Significant Deficiency Repeat
  • 1147639 2023-104
    Significant Deficiency
  • 1147640 2023-105
    Material Weakness
  • 1147641 2023-106
    Significant Deficiency
  • 1147642 2023-101
    Material Weakness Repeat
  • 1147643 2023-102
    Significant Deficiency Repeat
  • 1147644 2023-104
    Significant Deficiency
  • 1147645 2023-105
    Material Weakness
  • 1147646 2023-106
    Significant Deficiency
  • 1147647 2023-102
    Significant Deficiency Repeat
  • 1147648 2023-104
    Significant Deficiency
  • 1147649 2023-102
    Significant Deficiency Repeat
  • 1147650 2023-104
    Significant Deficiency
  • 1147651 2023-102
    Significant Deficiency Repeat
  • 1147652 2023-104
    Significant Deficiency
  • 1147653 2023-105
    Material Weakness
  • 1147654 2023-106
    Significant Deficiency
  • 1147655 2023-101
    Material Weakness Repeat
  • 1147656 2023-102
    Significant Deficiency Repeat
  • 1147657 2023-104
    Significant Deficiency
  • 1147658 2023-105
    Material Weakness
  • 1147659 2023-106
    Significant Deficiency
  • 1147660 2023-102
    Significant Deficiency Repeat
  • 1147661 2023-104
    Significant Deficiency
  • 1147662 2023-102
    Significant Deficiency Repeat
  • 1147664 2023-105
    Material Weakness
  • 1147665 2023-106
    Significant Deficiency
  • 1147666 2023-101
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.527 Grants for New and Expanded Services Under the Health Center Program $5.71M
93.527 Covid-19 Grants for New and Expanded Services Under the Health Center Program $450,175
10.855 Distance Learning and Telemedicine Loans and Grants $432,551
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $372,813
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $264,880
93.224 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $229,845
93.939 Hiv Prevention Activities Non-Governmental Organization Based $135,532
93.224 Covid-19 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $113,838
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $64,030
93.526 Covid-19 Grants for Capital Development in Health Centers $1,466